title: Phosphate supplementation, cardiovascular function, and exercise performance in humans.
abstract: The use of oral phosphate (Pi) supplements to improve muscular work performance has long been proposed without substantiating data. In a double-blind, crossover experiment 11 male runners ingested calcium Pi (176 mmol/day) or placebo for 4 days. On the 3rd treatment day, subjects ran an incremental maximal aerobic capacity test (VO2 max) on a treadmill, and on the 4th day a treadmill run to exhaustion at approximately 70% VO2max. By the 4th day of Pi loading, plasma Pi was significantly higher than control (P less than 0.05); however, erythrocyte Pi, 2,3-diphosphoglycerate, and O2 half-saturation pressure of hemoglobin (P50) were not elevated. VO2 max was not changed by the treatments (mean 62.9, 64.2, 64.9 ml.kg-1.min-1 for control, Pi, and placebo bouts, respectively) nor was submaximal run time to exhaustion (61.6 min for Pi, 65.5 min for placebo). Stroke volume at steady-state VO2 was decreased with Pi (P less than 0.05), whereas cardiac output tended (P = 0.07) to be lower. Greater arteriovenous O2 difference (P less than 0.05) with Pi suggested a peripheral effect that increased O2 extraction. We concluded that in healthy individuals Pi loading produced no improvement in work tolerance or aerobic capacity but did alter some aspects of cardiovascular function.
authors.affiliation: Department of Physical Education, Indiana University, Bloomington 47405.
authors.forename: D L
authors.initials: DL
authors.lastname: Bredle
authors.forename: J M
authors.initials: JM
authors.lastname: Stager
authors.forename: W F
authors.initials: WF
authors.lastname: Brechue
authors.forename: M O
authors.initials: MO
authors.lastname: Farber
mesh_terms: D019794:2,3-Diphosphoglycerate; D000328:Adult; D002302:Cardiac Output; D002320:Cardiovascular Physiological Phenomena; D004163:Diphosphoglyceric Acids / Q000097:blood; D004912:Erythrocytes / Q000378:metabolism; D015444:Exercise; D006454:Hemoglobins / Q000378:metabolism; D006801:Humans; D008297:Male; D010100:Oxygen / Q000097:blood; D010101:Oxygen Consumption / Q000187:drug effects; D010710:Phosphates / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology*; D013318:Stroke Volume
chemical_list: D004163:Diphosphoglyceric Acids; D006454:Hemoglobins; D010710:Phosphates; D019794:2,3-Diphosphoglycerate; D010100:Oxygen